Filter
1715
Filtered Results: 1715
Text search:
generics
Featured
Recommendations
165
New Publications
438
Language
Document type
No document type
995
Guidelines
250
Studies & Reports
234
Manuals
111
Strategic & Response Plan
56
Training Material
26
Fact sheets
23
Situation Updates
10
Infographics
4
Brochures
2
Resource Platforms
2
Online Courses
2
Countries / Regions
India
73
Global
70
Nepal
34
Ethiopia
33
Kenya
33
South Africa
32
Western and Central Europe
29
Nigeria
26
Uganda
25
Liberia
24
Tanzania
24
Myanmar / Burma
22
Africa
21
Sierra Leone
20
Bangladesh
20
Ghana
19
Zambia
19
Malawi
19
Ukraine
18
Rwanda
17
Latin America and the Carribbean
17
Namibia
13
Zimbabwe
11
Syria
11
Indonesia
11
Eastern Europe
11
Burkina Faso
10
Philippines
10
South–East Asia Region
10
Cambodia
8
Eswatini/ Swaziland
8
Asia
8
East and Southern Africa
7
Lesotho
6
Russia
6
Guinea
5
Senegal
5
Cameroon
5
Sri Lanka
5
West and Central Africa
5
Congo, Democratic Republic of
4
Haiti
4
Germany
4
Thailand
4
Mozambique
4
Benin
4
Botswana
4
Western Pacific Region
4
Vietnam
4
Pakistan
3
Sudan
3
Middle East and North Africa
3
Albania
3
South Sudan
2
Iraq
2
Jordan
2
Afghanistan
2
Brazil
2
Eastern Europe and Central Asia
2
Paraguay
2
Venezuela
2
Laos
2
Tajikistan
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Somalia
1
Lebanon
1
Turkey
1
China
1
Argentina
1
Peru
1
North Macedonia
1
Switzerland
1
Burundi
1
Colombia
1
Ecuador
1
Greece
1
Mexico
1
Chile
1
Fiji
1
Bhutan
1
North Korea
1
Southern Africa
1
Timor Leste/ East Timor
1
Bulgaria
1
Iran
1
Georgia
1
North America
1
France
1
Mauritius
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
530
Clinical Guidelines
171
Public Health
126
Key Resources
86
Women & Child Health
79
Capacity Building
39
Pharmacy & Technologies
34
Toolboxes
HIV
165
Mental Health
121
COVID-19
101
Pharmacy
92
AMR
78
TB
68
Rapid Response
54
Disability
53
Planetary Health
43
NCDs
42
Conflict
40
Ebola
39
Caregiver
33
NTDs
31
Global Health Education
29
Specific Hazards
24
Natural Hazards
23
Refugee
16
Health Financing Toolbox
15
Zika
10
Polio
9
Social Ethics
7
Cholera
4
Health Financing
2
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
The Mexico Declaration for Circulatory Health brings together global health
organizations committed to improving circulatory health and reducing deaths and disability from heart disease and stroke around the world. These diseases presently represent the biggest health burden world-wide, accounting ...
Since the Alma Ata Declaration in 1978, community health volunteers (CHVs) have been at the forefront, providing health services, especially to underserved communities, in low-income countries. However, consolidation of CHVs position within formal health systems has proved to be complex and continue...
For thousands of years, humans have been using wildlife for commercial and subsistence purposes. Wildlife trade takes place at local, national and international levels, with different forms of wildlife, such as live animals, partly processed products and finished products. Wildlife is a vital source...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Master of Science in Pharmaceutical Management Dissertation
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
